As healthcare costs continue to reshape institutional balance sheets, pharmacy benefits have emerged as one of the most complex and rapidly expanding components of total compensation strategy. Employers, universities, and nonprofit systems are increasingly recognizing that benefit structures once treated as administrative functions now require governance-level oversight, particularly as new federal transparency legislation introduces stricter expectations around pricing visibility, rebate disclosure, and fiduciary accountability. Within this shift, a new partnership model is beginning to take shape, one grounded in fiduciary alignment, education, and long-term stewardship of financial resources.
AffirmedRx operates within the pharmacy benefit management (PBM) sector as a Public Benefit Corporation (PBC), supporting institutions in the design, administration, and financial governance of prescription drug programs. Rather than functioning solely as an intermediary between payers and pharmaceutical supply chains, the organization's model centers on transparency, data visibility, and institutional alignment. According to Greg Baker, CEO of AffirmedRx, the evolution underway reflects a broader rethinking of responsibility within healthcare ecosystems.
